Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

CLVLF

Clinuvel Pharmaceuticals Limited

USD

Set alert

Price alert · CLVLF

All alert types
4.95 USD -0.10 -1.98%
As of Oct 30, 2026
4.95 Day range 5.04
4.95 52-week range 8.45
YTD
-35.71%
1 year
-28.88%
Open
5.04
Prev close
5.05
Mkt cap
249.91M
Vol
300
Avg vol
1.11K
EPS
0.45
P/E
11.00
More statistics
Low
4.95
High
5.04

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CLVLF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

11.47 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A+5 / 5 overall

  • DCF 5
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 4

Valuation

P/E 13.0×
FY 2017: 46.0×FY 2018: 39.8×FY 2019: 89.4×FY 2020: 79.9×FY 2021: 57.3×FY 2022: 33.6×FY 2023: 29.0×FY 2024: 21.1×FY 2025: 15.2×FY 2026: 13.0×
FY 2017 5y median 21.1× FY 2026
P/S 4.7×
FY 2017: 19.7×FY 2018: 20.9×FY 2019: 52.7×FY 2020: 37.5×FY 2021: 29.3×FY 2022: 10.6×FY 2023: 11.4×FY 2024: 8.6×FY 2025: 5.8×FY 2026: 4.7×
FY 2017 5y median 8.6× FY 2026
P/B 1.6×
FY 2017: 12.9×FY 2018: 13.5×FY 2019: 28.6×FY 2020: 16.6×FY 2021: 14.3×FY 2022: 5.6×FY 2023: 5.4×FY 2024: 3.7×FY 2025: 2.3×FY 2026: 1.6×
FY 2017 5y median 3.7× FY 2026
P/FCF 12.5×
FY 2017: 33.4×FY 2018: 45.8×FY 2019: 90.0×FY 2020: 91.8×FY 2021: 76.9×FY 2022: 17.7×FY 2023: 24.8×FY 2024: 24.0×FY 2025: 13.5×FY 2026: 12.5×
FY 2017 5y median 17.7× FY 2026
EV/EBITDA 9.8×
FY 2017: 44.5×FY 2018: 40.4×FY 2019: 86.3×FY 2020: 85.0×FY 2021: 47.3×FY 2022: 15.5×FY 2023: 14.8×FY 2024: 10.2×FY 2025: 5.7×FY 2026: 9.8×
FY 2017 5y median 10.2× FY 2026
EV/Sales 4.5×
FY 2017: 18.2×FY 2018: 19.4×FY 2019: 51.0×FY 2020: 35.5×FY 2021: 27.6×FY 2022: 8.8×FY 2023: 9.4×FY 2024: 6.5×FY 2025: 3.4×FY 2026: 4.5×
FY 2017 5y median 6.5× FY 2026
FCF Yield 8.0%
FY 2017: 3.0%FY 2018: 2.2%FY 2019: 1.1%FY 2020: 1.1%FY 2021: 1.3%FY 2022: 5.7%FY 2023: 4.0%FY 2024: 4.2%FY 2025: 7.4%FY 2026: 8.0%
FY 2017 5y median 5.7% FY 2026

Profitability

Gross Margin 83.3%
FY 2017: 75.8%FY 2018: 76.5%FY 2019: 77.9%FY 2020: 70.4%FY 2021: 89.5%FY 2022: 84.0%FY 2023: 88.8%FY 2024: 91.2%FY 2025: 83.3%FY 2026: 83.3%
FY 2017 5y median 84.0% FY 2026
Operating Margin 43.1%
FY 2017: 40.1%FY 2018: 47.7%FY 2019: 58.4%FY 2020: 40.4%FY 2021: 60.9%FY 2022: 54.9%FY 2023: 57.3%FY 2024: 54.4%FY 2025: 48.1%FY 2026: 43.1%
FY 2017 5y median 54.4% FY 2026
Net Margin 36.1%
FY 2017: 42.9%FY 2018: 51.9%FY 2019: 58.4%FY 2020: 51.1%FY 2021: 51.2%FY 2022: 31.8%FY 2023: 39.1%FY 2024: 40.4%FY 2025: 38.1%FY 2026: 36.1%
FY 2017 5y median 38.1% FY 2026
ROE 12.4%
FY 2017: 28.3%FY 2018: 33.6%FY 2019: 31.7%FY 2020: 22.6%FY 2021: 25.0%FY 2022: 16.6%FY 2023: 18.6%FY 2024: 17.6%FY 2025: 15.0%FY 2026: 12.4%
FY 2017 5y median 16.6% FY 2026
ROIC 10.4%
FY 2017: 26.3%FY 2018: 30.8%FY 2019: 31.5%FY 2020: 17.5%FY 2021: 28.3%FY 2022: 16.8%FY 2023: 17.9%FY 2024: 16.4%FY 2025: 13.1%FY 2026: 10.4%
FY 2017 5y median 16.4% FY 2026
ROA 11.5%
FY 2017: 25.1%FY 2018: 30.8%FY 2019: 29.1%FY 2020: 20.4%FY 2021: 22.8%FY 2022: 14.5%FY 2023: 15.8%FY 2024: 15.4%FY 2025: 13.3%FY 2026: 11.5%
FY 2017 5y median 14.5% FY 2026

Growth (YoY)

Revenue -1.2%
FY 2017: 169.2%FY 2018: 52.4%FY 2019: 21.8%FY 2020: 4.9%FY 2021: 48.4%FY 2022: 36.0%FY 2023: 19.2%FY 2024: 12.6%FY 2025: 7.8%FY 2026: -1.2%
FY 2017 FY 2026
Operating Income -11.5%
FY 2017: 260.1%FY 2018: 81.3%FY 2019: 49.3%FY 2020: -27.4%FY 2021: 123.6%FY 2022: 22.6%FY 2023: 24.4%FY 2024: 6.9%FY 2025: -4.7%FY 2026: -11.5%
FY 2017 FY 2026
EPS (diluted) -5.6%
FY 2017: 301.1%FY 2018: 92.9%FY 2019: 37.0%FY 2020: -18.9%FY 2021: 60.0%FY 2022: -16.7%FY 2023: 47.5%FY 2024: 18.6%FY 2025: 2.9%FY 2026: -5.6%
FY 2017 FY 2026
Free Cash Flow -13.6%
FY 2017: 291.8%FY 2018: 18.0%FY 2019: 56.6%FY 2020: -26.9%FY 2021: 38.4%FY 2022: 114.2%FY 2023: -9.0%FY 2024: -12.3%FY 2025: 29.6%FY 2026: -13.6%
FY 2017 FY 2026

Financial Health

Current Ratio 14.8×
FY 2017: 9.0×FY 2018: 12.2×FY 2019: 12.3×FY 2020: 11.3×FY 2021: 11.8×FY 2022: 10.2×FY 2023: 7.4×FY 2024: 8.8×FY 2025: 9.7×FY 2026: 14.8×
FY 2017 5y median 9.7× FY 2026
Quick Ratio 14.5×
FY 2017: 8.7×FY 2018: 12.0×FY 2019: 11.9×FY 2020: 11.1×FY 2021: 11.4×FY 2022: 10.1×FY 2023: 7.1×FY 2024: 8.4×FY 2025: 9.3×FY 2026: 14.5×
FY 2017 5y median 9.3× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA -0.4×
FY 2017: -3.5×FY 2018: -3.0×FY 2019: -2.9×FY 2020: -4.8×FY 2021: -2.9×FY 2022: -3.2×FY 2023: -3.1×FY 2024: -3.3×FY 2025: -3.9×FY 2026: -0.4×
FY 2017 5y median -3.2× FY 2026
Interest Coverage 499×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 859×FY 2020: 508×FY 2021: 18.2×FY 2022: 15.9×FY 2023: 14.1×FY 2024: 10.8×FY 2025: 10.2×FY 2026: 499×
FY 2017 5y median 14.1× FY 2026

Dividends

Dividend Yield 0.6%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.1%FY 2020: 0.1%FY 2021: 0.1%FY 2022: 0.2%FY 2023: 0.2%FY 2024: 0.3%FY 2025: 0.5%FY 2026: 0.6%
FY 2017 5y median 0.3% FY 2026
Payout Ratio 7.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 5.3%FY 2020: 7.4%FY 2021: 5.0%FY 2022: 5.9%FY 2023: 6.5%FY 2024: 6.9%FY 2025: 6.9%FY 2026: 7.4%
FY 2017 5y median 6.9% FY 2026

Annual · latest fiscal year ends 2026-06-30